Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:29204055  

Combined treatment of pancreatic cancer xenograft with 90Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor.

Winn Aung | Atsushi B Tsuji | Hitomi Sudo | Aya Sugyo | Yoshinori Ukai | Katsushi Kouda | Yoshikazu Kurosawa | Takako Furukawa | Tsuneo Saga | Tatsuya Higashi
World journal of gastroenterology | 2017

To investigate the therapeutic effect of combined integrin α6β4-targeted radioimmunotherapy (RIT) and PI3K/mTOR inhibitor BEZ235 in a pancreatic cancer model.

Pubmed ID: 29204055

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BxPC-3 (tool)

RRID:CVCL_0186

Cell line BxPC-3 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions